RICHARD L. WOOTEN, M.D.; FRANKLIN A. KYSER, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
During the past several years, numerous studies have appeared in the medical literature regarding the treatment of acute myocardial infarction. Mortality rates in this condition have been reported as varying from 81 per cent7 to 50 per cent,5 while the incidence of embolic phenomena is stated to vary from 1 per cent to 37 per cent. The use of anticoagulant therapy has been enthusiastically advocated by Wright,1 Nichol and Page2 and Parker and Barker.3 Other, more conservative investigators4, 5, 6 deny the need for routine use of anticoagulants in acute myocardial infarction.
The practicing physician cannot help but be bewildered
WOOTEN RL, KYSER FA. MORTALITY, MORBIDITY AND TREATMENT OF MYOCARDIAL INFARCTION: A REVIEW OF 455 CASES*. Ann Intern Med. 1953;38:247–253. doi: https://doi.org/10.7326/0003-4819-38-2-247
Download citation file:
Published: Ann Intern Med. 1953;38(2):247-253.
Acute Coronary Syndromes, Cardiology, Coronary Heart Disease, Emergency Medicine.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use